These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 24591408

  • 1. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J, Ahn S, Shin JH, Oh YL.
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [Abstract] [Full Text] [Related]

  • 2. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C, Sgariglia R, Migliatico I, Vigliar E, D'Anna M, Nacchio MA, Serra N, Malapelle U, Bongiovanni M, Troncone G.
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [Abstract] [Full Text] [Related]

  • 3. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS, Hirschowitz SL, Fung PC, Apple SK.
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [Abstract] [Full Text] [Related]

  • 4. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.
    Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
    [Abstract] [Full Text] [Related]

  • 5. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G.
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [Abstract] [Full Text] [Related]

  • 6. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
    Kim SJ, Roh J, Baek JH, Hong SJ, Shong YK, Kim WB, Song DE.
    Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
    [Abstract] [Full Text] [Related]

  • 7. Significance of Subcategory Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Showing Both Cytologic and Architectural Atypia in Thyroid Aspiration Cytology.
    Jung YY, Jung S, Lee HW, Oh YL.
    Acta Cytol; 2015 Feb; 59(5):370-6. PubMed ID: 26529329
    [Abstract] [Full Text] [Related]

  • 8. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
    Jeong SH, Hong HS, Lee EH, Cha JG, Park JS, Kwak JJ.
    AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
    [Abstract] [Full Text] [Related]

  • 9. Thyroid "atypia of undetermined significance" with nuclear atypia has high rates of malignancy and BRAF mutation.
    Park HJ, Moon JH, Yom CK, Kim KH, Choi JY, Choi SI, Ahn SH, Jeong WJ, Lee WW, Park SY.
    Cancer Cytopathol; 2014 Jul; 122(7):512-20. PubMed ID: 24619974
    [Abstract] [Full Text] [Related]

  • 10. Follicular lesion of undetermined significance in thyroid FNA revisited.
    Walts AE, Mirocha J, Bose S.
    Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH, Baek JH, Lee JH, Choi YJ, Song DE, Chung KW, Kim TY, Shong YK.
    Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
    [Abstract] [Full Text] [Related]

  • 12. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients.
    Arva NC, Deitch SG.
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):753-60. PubMed ID: 25879311
    [Abstract] [Full Text] [Related]

  • 13. The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Strupas K.
    Langenbecks Arch Surg; 2017 Mar; 402(2):227-234. PubMed ID: 28160058
    [Abstract] [Full Text] [Related]

  • 14. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH, Han K, Kim EK, Moon HJ, Yoon JH, Park VY, Kwak JY.
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [Abstract] [Full Text] [Related]

  • 15. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
    Faquin WC, Baloch ZW.
    Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
    [Abstract] [Full Text] [Related]

  • 16. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".
    Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE.
    Cancer Cytopathol; 2010 Feb 25; 118(1):17-23. PubMed ID: 20099311
    [Abstract] [Full Text] [Related]

  • 17. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, Song DE, Shong YK, Hong SJ.
    Thyroid; 2014 Mar 25; 24(3):494-501. PubMed ID: 23947771
    [Abstract] [Full Text] [Related]

  • 18. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
    Yoon JH, Kwon HJ, Kim EK, Moon HJ, Kwak JY.
    Clin Endocrinol (Oxf); 2016 Aug 25; 85(2):275-82. PubMed ID: 26639612
    [Abstract] [Full Text] [Related]

  • 19. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, Cakir B, Guler G.
    Cytopathology; 2014 Jun 25; 25(3):185-9. PubMed ID: 24024935
    [Abstract] [Full Text] [Related]

  • 20. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
    Seagrove-Guffey MA, Hatic H, Peng H, Bates KC, Odugbesan AO.
    Cancer Cytopathol; 2018 Oct 25; 126(10):881-888. PubMed ID: 30335212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.